
Revela Biotech LLC
Bringing Together a Team with Broad Experience in Immunology and Diagnostic Imaging.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
$750k | Early VC | ||
Total Funding | 000k |
Revela Biotech operates at the intersection of biotechnology and artificial intelligence, primarily focusing on the discovery of novel molecules for the beauty and wellness industry. Founded in 2021 by Dr. Evan Zhao, Dr. David Zhang, Avi Boppana, and Ying Tung (Evelyn) Chen, the team brings together expertise in synthetic biology, machine learning, and high-throughput screening from institutions like Harvard and MIT. The founders' journey began during the 2020 pandemic when, unable to work in their respective university labs on cancer treatments, they decided to apply their advanced scientific backgrounds to address widespread consumer challenges. They identified the beauty and wellness space as an industry that had seen limited scientific advancement for decades.
The company's core business revolves around its AI-powered molecular discovery platform. This technology sifts through vast molecular libraries to identify new, safe, and highly effective ingredients. Revela then validates these discoveries through sophisticated biological models before product integration. Its business model initially involved developing and marketing its own direct-to-consumer products, such as its Hair Revival Serum featuring the proprietary molecule ProCelinyl, which was engineered to improve hair follicle health. This approach demonstrated the platform's capability to move beyond repackaging existing ingredients and to introduce entirely new compounds to the market.
In a significant milestone, Revela was acquired by ODDITY, the parent company of IL MAKIAGE and Spoiled Child, in April 2023 for $76 million. Following the acquisition, ODDITY established ODDITY LABS in Boston, led by the Revela founding team, with an additional $25 million investment. As a result, the Revela consumer brand was wound down, and its pipeline of molecules is now being integrated into ODDITY's existing and future brands. This positions Revela's technology as the central R&D engine for ODDITY, aiming to develop a new generation of science-backed products across skincare, haircare, and total wellness.
Keywords: AI molecule discovery, beauty biotechnology, wellness ingredients, computational biology, synthetic biology, skincare innovation, haircare science, drug discovery platform, consumer wellness, molecular engineering, ProCelinyl, Fibroquin, ODDITY LABS, Evan Zhao, David Zhang, high-throughput screening, novel cosmetic ingredients, AI-driven R&D, beauty tech, advanced biological models, personalized beauty